Menu Search
Equities

Brightspring Health Services Inc

BTSG:NSQ

Brightspring Health Services Inc

Actions
Health CareHealth Care Providers
  • Price (USD)19.57
  • Today's Change0.65 / 3.44%
  • Shares traded1.77m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Brightspring Health Services Inc had net income fall 186.80% from a loss of 53.91m to a larger loss of 154.60m despite a 14.32% increase in revenues from 7.72bn to 8.83bn. An increase in the cost of goods sold as a percentage of sales from 82.46% to 83.76% was a component in the falling net income despite rising revenues.
Gross margin14.50%
Net profit margin-0.41%
Operating margin1.73%
Return on assets-0.76%
Return on equity-3.61%
Return on investment-0.97%
More ▼

Cash flow in USDView more

In 2023, Brightspring Health Services Inc did not generate a significant amount of cash. However, the company earned 210.78m from its operations for a Cash Flow Margin of 2.39%. In addition the company used 134.43m on investing activities and also paid 76.91m in financing cash flows.
Cash flow per share0.8988
Price/Cash flow per share21.64
Book value per share9.28
Tangible book value per share-10.92
More ▼

Balance sheet in USDView more

Brightspring Health Services Inc has a Debt to Total Capital ratio of 62.47%, a lower figure than the previous year's 550.94%.
Current ratio1.35
Quick ratio0.9742
Total debt/total equity1.67
Total debt/total capital0.6247
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.